Literature DB >> 25336643

Mutation of three residues in the third intracellular loop of the dopamine D2 receptor creates an internalization-defective receptor.

Cecilea C Clayton1, Prashant Donthamsetti2, Nevin A Lambert3, Jonathan A Javitch4, Kim A Neve5.   

Abstract

Arrestins mediate desensitization and internalization of G protein-coupled receptors and also direct receptor signaling toward heterotrimeric G protein-independent signaling pathways. We previously identified a four-residue segment (residues 212-215) of the dopamine D2 receptor that is necessary for arrestin binding in an in vitro heterologous expression system but that also impairs receptor expression. We now describe the characterization of additional mutations at that arrestin binding site in the third intracellular loop. Mutating two (residues 214 and 215) or three (residues 213-215) of the four residues to alanine partially decreased agonist-induced recruitment of arrestin3 without altering activation of a G protein. Arrestin-dependent receptor internalization, which requires arrestin binding to β2-adaptin (the β2 subunit of the clathrin-associated adaptor protein AP2) and clathrin, was disproportionately affected by the three-residue mutation, with no agonist-induced internalization observed even in the presence of overexpressed arrestin or G protein-coupled receptor kinase 2. The disjunction between arrestin recruitment and internalization could not be explained by alterations in the time course of the receptor-arrestin interaction, the recruitment of G protein-coupled receptor kinase 2, or the receptor-induced interaction between arrestin and β2-adaptin, suggesting that the mutation impairs a property of the internalization complex that has not yet been identified.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Adenylate Cyclase (Adenylyl Cyclase); Arrestin; Bioluminescence Resonance Energy Transfer (BRET); Dopamine Receptor; G Protein; beta2-Adaptin

Mesh:

Substances:

Year:  2014        PMID: 25336643      PMCID: PMC4246117          DOI: 10.1074/jbc.M114.605378

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors.

Authors:  K Iwata; K Ito; A Fukuzaki; K Inaki; T Haga
Journal:  Eur J Biochem       Date:  1999-07

Review 2.  Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking.

Authors:  Dong Soo Kang; Xufan Tian; Jeffrey L Benovic
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

Review 3.  Functional selectivity and classical concepts of quantitative pharmacology.

Authors:  Jonathan D Urban; William P Clarke; Mark von Zastrow; David E Nichols; Brian Kobilka; Harel Weinstein; Jonathan A Javitch; Bryan L Roth; Arthur Christopoulos; Patrick M Sexton; Keith J Miller; Michael Spedding; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2006-06-27       Impact factor: 4.030

Review 4.  GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling.

Authors:  Eric Reiter; Robert J Lefkowitz
Journal:  Trends Endocrinol Metab       Date:  2006-04-03       Impact factor: 12.015

5.  Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway.

Authors:  Lily I Jiang; Julie Collins; Richard Davis; Keng-Mean Lin; Dianne DeCamp; Tamara Roach; Robert Hsueh; Robert A Rebres; Elliott M Ross; Ronald Taussig; Iain Fraser; Paul C Sternweis
Journal:  J Biol Chem       Date:  2007-02-05       Impact factor: 5.157

6.  Gz proteins are functionally coupled to dopamine D2-like receptors in vivo.

Authors:  Kwong J Leck; Charles D Blaha; Klaus I Matthaei; Gina L Forster; Joan Holgate; Ian A Hendry
Journal:  Neuropharmacology       Date:  2006-06-30       Impact factor: 5.250

7.  G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer.

Authors:  Jonathan D Violin; Xiu-Rong Ren; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

8.  Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions.

Authors:  Kevin D G Pfleger; Ruth M Seeber; Karin A Eidne
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

9.  An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior.

Authors:  Jean-Martin Beaulieu; Tatyana D Sotnikova; Sébastien Marion; Robert J Lefkowitz; Raul R Gainetdinov; Marc G Caron
Journal:  Cell       Date:  2005-07-29       Impact factor: 41.582

10.  Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons.

Authors:  Tara A Macey; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2004-09-10       Impact factor: 4.436

View more
  15 in total

Review 1.  Extramembranous Regions in G Protein-Coupled Receptors: Cinderella in Receptor Biology?

Authors:  Sreetama Pal; Amitabha Chattopadhyay
Journal:  J Membr Biol       Date:  2019-08-30       Impact factor: 1.843

2.  GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision.

Authors:  Wesley B Asher; Daniel S Terry; G Glenn A Gregorio; Alem W Kahsai; Alessandro Borgia; Bing Xie; Arnab Modak; Ying Zhu; Wonjo Jang; Alekhya Govindaraju; Li-Yin Huang; Asuka Inoue; Nevin A Lambert; Vsevolod V Gurevich; Lei Shi; Robert J Lefkowitz; Scott C Blanchard; Jonathan A Javitch
Journal:  Cell       Date:  2022-04-27       Impact factor: 66.850

3.  Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.

Authors:  Andrew C Kruegel; Madalee M Gassaway; Abhijeet Kapoor; András Váradi; Susruta Majumdar; Marta Filizola; Jonathan A Javitch; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2016-05-18       Impact factor: 15.419

4.  Optical Control of Dopamine Receptors Using a Photoswitchable Tethered Inverse Agonist.

Authors:  Prashant C Donthamsetti; Nils Winter; Matthias Schönberger; Joshua Levitz; Cherise Stanley; Jonathan A Javitch; Ehud Y Isacoff; Dirk Trauner
Journal:  J Am Chem Soc       Date:  2017-12-13       Impact factor: 15.419

5.  Using Bioluminescence Resonance Energy Transfer (BRET) to Characterize Agonist-Induced Arrestin Recruitment to Modified and Unmodified G Protein-Coupled Receptors.

Authors:  Prashant Donthamsetti; Jose Rafael Quejada; Jonathan A Javitch; Vsevolod V Gurevich; Nevin A Lambert
Journal:  Curr Protoc Pharmacol       Date:  2015-09-01

6.  Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.

Authors:  Marta Sánchez-Soto; Alessandro Bonifazi; Ning Sheng Cai; Michael P Ellenberger; Amy Hauck Newman; Sergi Ferré; Hideaki Yano
Journal:  Mol Pharmacol       Date:  2016-02-03       Impact factor: 4.436

7.  Signaling-Biased and Constitutively Active Dopamine D2 Receptor Variant.

Authors:  Dayana Rodriguez-Contreras; Alec F Condon; David C Buck; Naeem Asad; Timothy M Dore; Dineke S Verbeek; Marina A J Tijssen; Ujwal Shinde; John T Williams; Kim A Neve
Journal:  ACS Chem Neurosci       Date:  2021-05-11       Impact factor: 5.780

8.  Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.

Authors:  Sean M Peterson; Thomas F Pack; Marc G Caron
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

9.  Desensitized D2 autoreceptors are resistant to trafficking.

Authors:  Brooks G Robinson; James R Bunzow; Jonathan B Grimm; Luke D Lavis; Joshua T Dudman; Jennifer Brown; Kim A Neve; John T Williams
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

10.  Visualization of ligand-induced dopamine D2S and D2L receptor internalization by TIRF microscopy.

Authors:  Alina Tabor; Dorothee Möller; Harald Hübner; Johannes Kornhuber; Peter Gmeiner
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.